Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mylan's Manufacturing Maelstrom: Trans-Atlantic Recalls And Personal Citation By Gottlieb

Executive Summary

GMP quality, once Mylan's calling card, is now an ongoing problem, forcing product discontinuations and apologies to customers. Firm's valsartan products have European certificate of suitability suspended as Morgantown, W.Va. facility draws US FDA warning letter.
Advertisement

Related Content

Swift And Nimble – Alembic Laps Up US Valsartan Windfall In Q2
The Quality Lowdown: Recalls And Shortages
The Quality Lowdown: Cleaning Issues At Mylan, Blank Release Forms At API Plant In China, And More
Mylan’s EpiPen Recall: Adding Insult To An Injured Product
Mylan Gets First-Ever GMP Warning Letter
Establishment Fees Protect American Manufacturing, Mylan Argues In User Fee Proposal

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124304

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel